华恒生物
(688639)
| 流通市值：46.92亿 | | | 总市值：46.92亿 |
| 流通股本：2.50亿 | | | 总股本：2.50亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,632,264,595.09 | 771,264,504.42 | 2,861,841,123.69 | 2,193,542,266.71 |
| 营业总成本 | 1,541,796,088.26 | 736,379,623.79 | 2,744,165,757.74 | 2,022,179,740.12 |
| 其他经营收益 | | | | |
| 营业利润 | 96,556,973.65 | 38,412,949.18 | 129,653,437.59 | 174,450,674.85 |
| 利润总额 | 93,187,207.16 | 35,904,588.5 | 125,557,074.99 | 171,328,066.51 |
| 净利润 | 87,674,653.84 | 37,525,795.77 | 123,861,236.18 | 159,424,732.82 |
| 每股收益 | | | | |
| 其他综合收益 | -1,252,503.25 | -532,923.39 | -532,114.32 | -253,721.72 |
| 综合收益总额 | 86,422,150.59 | 36,992,872.38 | 123,329,121.86 | 159,171,011.1 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,807,138,476.02 | 1,732,214,300.61 | 1,464,083,098.23 | 1,654,263,099.65 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,324,590,671.04 | 4,293,700,031.81 | 4,310,598,381.22 | 4,017,402,181.77 |
| 资产总计 | 6,131,729,147.06 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 |
| 流动负债: | | | | |
| 流动负债合计 | 1,482,459,352.89 | 1,427,779,917.22 | 1,339,322,141.97 | 1,145,168,292.32 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,970,926,911.84 | 1,929,281,756.2 | 1,803,499,550.86 | 1,858,795,313.24 |
| 负债合计 | 3,453,386,264.73 | 3,357,061,673.42 | 3,142,821,692.83 | 3,003,963,605.56 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,706,348,262.93 | 2,688,246,517.27 | 2,646,682,105.35 | 2,682,169,896.03 |
| 股东权益合计 | 2,678,342,882.33 | 2,668,852,659 | 2,631,859,786.62 | 2,667,701,675.86 |
| 负债和股东权益合计 | 6,131,729,147.06 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,654,316,537.76 | 816,800,729.15 | 2,870,866,338.29 | 2,252,920,988.18 |
| 经营活动现金流出小计 | 1,579,911,314.25 | 803,728,355.82 | 2,766,319,667.2 | 2,138,179,477.18 |
| 经营活动产生的现金流量净额 | 74,405,223.51 | 13,072,373.33 | 104,546,671.09 | 114,741,511 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 9,270,899.02 | - | 2,087,534.51 | 37,856.7 |
| 投资活动现金流出小计 | 281,922,379.62 | 171,340,742.42 | 645,543,403 | 404,489,353.24 |
| 投资活动产生的现金流量净额 | -272,651,480.6 | -171,340,742.42 | -643,455,868.49 | -404,451,496.54 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,026,467,957.77 | 667,003,401.88 | 1,722,983,807.07 | 1,458,093,321.39 |
| 筹资活动现金流出小计 | 555,659,846.94 | 343,403,598.96 | 1,313,764,434.96 | 1,092,135,582.08 |
| 筹资活动产生的现金流量净额 | 470,808,110.83 | 323,599,802.92 | 409,219,372.11 | 365,957,739.31 |
| 汇率变动对现金及现金等价物的影响 | -6,978,731.47 | -3,274,039.73 | -1,147,319.18 | 1,745,348.3 |
| 现金及现金等价物净增加额 | 265,583,122.27 | 162,057,394.1 | -130,837,144.47 | 77,993,102.07 |
| 期末现金及现金等价物余额 | 549,705,328.7 | 446,179,600.53 | 284,122,206.43 | 492,952,452.97 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 265,583,122.27 | - | -130,837,144.47 | - |
最新报告期：2026-08-24| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 张雄,庄汀洲 | 1.12 | 1.24 | 1.37 | 2026-08-24 |